Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County

Journal of Medical Virology

Volumn 84, Issue 5, 2012, Pages 777-785

  Kelesidis, Theodoros ^a   Humphries, Romney ^a   Terashita, Dawn ^b   Eshaghian, Shahrooz ^a   Territo, Mary C ^a   Said, Jonathan ^a   Lewinski, Michael ^a   Currier, Judith S ^a   Pegues, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Acute Communicable Disease Control Program   (United States)

Author keywords

California; Epstein Barr virus; Hemophagocytic lymphohistiocytosis

Indexed keywords

FERRITIN; LEUCINE;

ADULT; ARTICLE; CODON; COPY NUMBER VARIATION; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; GENE SEQUENCE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VIRUS LOAD; VIRUS REACTIVATION;

ADULT; AMINO ACID SEQUENCE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; LOS ANGELES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; YOUNG ADULT;

HUMAN HERPESVIRUS 4;

EID: 84858592307     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23267     Document Type: Article

References (31)

1. Ahn JS, Rew SY, Shin MG, Kim Yang DH, Cho D, Kim SH, Bae SY, Lee SR, Kim YK, Kim HJ, Lee JJ. 2010. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 85: 719- 722.
2. Aitken CS, Sengupta K, Aedes C, Moss DJ, Sculley TB. 1994. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol 75: 95- 100.
3. Belyea B, Hinson A, Moran C, Hwang E, Heath J, Barfield R. 2010. Spontaneous resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 55: 754- 756.
4. Beutel K, Gross-Wieltsch U, Wiesel T, Stadt UZ, Janka G, Wagner HJ. 2009. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer 53: 184- 190.
5. Brodkin DE, Hobohm DW, Nigam R. 2008. Nasal-type NK/T-cell lymphoma presenting as hemophagocytic syndrome in an 11-year-old Mexican boy. J Pediatr Hematol Oncol 30: 938- 940.
6. Chen RL, Su IJ, Lin KH, Lee SH, Lin DT, Chuu WM, Lin KS, Huang LM, Lee CY. 1991. Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis. An atypical form of Epstein-Barr virus infection. Am J Clin Pathol 96: 171- 176.
7. Filipovich AH. 2009. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program 127- 131. PMID 20008190
8. Fisman DN. 2000. Hemophagocytic syndromes and infection. Emerg Infect Dis 6: 601- 608.
9. Fox CP, Shannon-Lowe C, Gothard P, Kishore B, Neilson J, O'Connor N, Rowe M. 2010. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells. Clin Infect Dis 51: 66- 69.
10. Gulley ML, Tang W. 2008. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 10: 279- 292.
11. Gupta A, Weitzman S, Abdelhaleem M. 2008. The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 50: 192- 194.
12. Halasa NB, Whitlock JA, McCurley TL, Smith JA, Zhu Q, Ochs H, Dermody TS, Crowe JE. 2003. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein. Clin Infect Dis 37: e136- e141.
13. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. 2007. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124- 131.
14. Imashuku S. 2002. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44: 259- 272.
15. Imashuku S. 2009. Infection of T lymphocytes in non-Asian patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 53: 1359.
16. Imashuku S. 2011. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010. J Pediatr Hematol Oncol 33: 35- 39.
17. Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S. 2001. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19: 2665- 2673.
18. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K, Kawa K. 2007. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86: 58- 65.
19. Kasahara Y, Yachie A. 2002. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 44: 283- 294.
20. Kaza U, Knight AK, Jeroudi M, Bocchini JA, Anga A, Bahna SL. 2008. A boy with fever, lymphadenopathy, hepatosplenomegaly, and lymphocytosis. Allergy Asthma Proc 29: 216- 220.
21. Kimura H. 2006. Pathogenesis of chronic active Epstein-Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 16: 251- 261.
22. Lindemann TL, Greene JS. 2005. Persistent cervical lymphadenopathy in an adolescent with Epstein-Barr induced hemophagocytic syndrome: Manifestations of a rare but often fatal disease. Int J Pediatr Otorhinolaryngol 69: 1011- 1014.
23. Mendes TM, Oliveira LC, Yamamoto L, Del Negro GM, Okay TS. 2008. Epstein-Barr virus nuclear antigen-2 detection and typing in immunocompromised children correlated with lymphoproliferative disorder biopsy findings. Braz J Infect Dis 12: 186- 191.
24. Mischler M, Fleming GM, Shanley TP, Madden L, Levine J, Castle V, Filipovich AH, Cornell TT. 2007. Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease: A mimicker of sepsis in the pediatric intensive care unit. Pediatrics 119: e1212- e1218.
25. Niece JA, Rogers ZR, Ahmad N, Langevin AM, McClain KL. 2010. Hemophagocytic lymphohistiocytosis in Texas: Observations on ethnicity and race. Pediatr Blood Cancer 54: 424- 428.
26. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES. 2000. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: A distinct clinicopathologic syndrome. Blood 96: 443- 451.
27. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. 2007. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7: 814- 822.
28. Schuster V, Ott G, Seidenspinner S, Kreth HW. 1996. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood 87: 1579- 1585.
29. Sonke GS, Ludwig I, van Oosten H, Baars JW, Meijer E, Kater AP, de Jong D. 2008. Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients. Clin Infect Dis 47: 105- 108.
30. Tabata YS, Teramura T, Kuriyama K, Yagi T, Todo S, Sawada T, Imashuku S. 2000. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Leuk Lymphoma 38: 373- 380.
31. Teramura T, Tabata Y, Yagi T, Morimoto A, Hibi S, Imashuku S. 2002. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma 43: 173- 179.